Home > Insider Trading > Filing (0001209191-23-030918)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1117480	Chimerix Inc	CMRX	Pharmaceutical Preparations (2834)	330903395

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1698751	T. Michael Andriole	2505 Meridian Parkway, Suite 100 Durham NC 27713	Chief Business Officer And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-05-18	51,700	$1.14	357,015	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.135 to $1.15, inclusive. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
Includes 10,416 shares acquired under the Issuer's Employee Stock Purchase Plan on March 10, 2023.
The 357,015 shares includes, 32,175 restricted stock unit awards ("RSUs") that were granted on January 17, 2023, of which 8,043 shares subject to the RSUs will vest on the one-year anniversary of the date of grant, 8,043 shares subject to the RSUs will vest on the second-year anniversary of the date of grant, 8,043 shares subject to the RSUs will vest on the third-year anniversary of the date of grant, and 8,046 shares subject to the RSUs will vest on the fourth-year anniversary of the date of grant.